Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of the naturally occurring cyclic hydroxamate dealanylalahopcin, which is an inhibitor of procollagen prolyl-4-hydroxylase, were synthesised and shown to be inhibitors of the human hypoxia-inducible factor prolyl hydroxylases.

Библиографические подробности
Главные авторы:	Schlemminger, I, Mole, D, McNeill, L, Dhanda, A, Hewitson, K, Tian, Y, Ratcliffe, P, Pugh, C, Schofield, C
Формат:	Journal article
Язык:	English
Опубликовано:	2003

Схожие документы

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
по: Mole, D, и др.
Опубликовано: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
по: McNeill, L, и др.
Опубликовано: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
по: Tuckerman, JR, и др.
Опубликовано: (2004)

Regulation of HIF: prolyl hydroxylases.
по: Stolze, I, и др.
Опубликовано: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
по: Chan, M, и др.
Опубликовано: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
по: Yeoh, K, и др.
Опубликовано: (2013)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
по: Yeh, TL, и др.
Опубликовано: (2017)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
по: Tian, Y, и др.
Опубликовано: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
по: Chowdhury, R, и др.
Опубликовано: (2016)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
по: Mecinović, J, и др.
Опубликовано: (2009)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
по: Hewitson, K, и др.
Опубликовано: (2007)

Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
по: Elkins, J, и др.
Опубликовано: (2003)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
по: Holt-Martyn, JP, и др.
Опубликовано: (2019)

ENANTIOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
по: Baldwin, J, и др.
Опубликовано: (1990)

STEREOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
по: Baldwin, J, и др.
Опубликовано: (1990)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
по: Cockman, M, и др.
Опубликовано: (2019)

Inhibition of hypoxia inducible factor (HIF) hydroxylases
по: Conejo-Garcia, A, и др.
Опубликовано: (2005)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
по: Chowdhury, R, и др.
Опубликовано: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
по: Rasheduzzaman Chowdhury, и др.
Опубликовано: (2016-08-01)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
по: Masson, N, и др.
Опубликовано: (2004)

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
по: Hewitson, K, и др.
Опубликовано: (2002)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
по: Matthew E Cockman, и др.
Опубликовано: (2019-09-01)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
по: Epstein, A, и др.
Опубликовано: (2001)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
по: Willam, C, и др.
Опубликовано: (2006)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
по: Masson, N, и др.
Опубликовано: (2003)

Oxygen sensing by HIF hydroxylases.
по: Schofield, C, и др.
Опубликовано: (2004)

Signalling hypoxia by HIF hydroxylases.
по: Schofield, C, и др.
Опубликовано: (2005)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
по: Andrey A. Poloznikov, и др.
Опубликовано: (2021-01-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
по: Mayer, M, и др.
Опубликовано: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
по: Takahiro Kambara, и др.
Опубликовано: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
по: Kiichi Hirota
Опубликовано: (2021-04-01)

Iron homeostasis and its interaction with prolyl hydroxylases.
по: Mole, D
Опубликовано: (2010)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
по: Singh, A, и др.
Опубликовано: (2020)

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
по: McNeill, L, и др.
Опубликовано: (2005)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
по: Chen, R, и др.
Опубликовано: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
по: Chen, R, и др.
Опубликовано: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
по: Flashman, E, и др.
Опубликовано: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
по: Astuti, D, и др.
Опубликовано: (2011)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
по: Astuti, D, и др.
Опубликовано: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
по: Moritz J. Strowitzki, и др.
Опубликовано: (2021-04-01)